
Fellowship
H7 BioCapital is a Silicon Valley-based venture capital firm dedicated to life science investment, including therapeutics, medtech, and pharmaceutical innovation. The firm opened its H7 Investment Fellowship program in 2026, offering a comprehensive 6-month experience in biotech venture capital for candidates with advanced scientific degrees. The fellowship provides hands-on training in investment due diligence, deal negotiation, and investment thesis development within the biotech sector, with personalized mentorship and industry networking.
Join the Superscout community!
🌍 Meet other scouts globally.
👀 Get first dibs on new scout programs and VC openings.
✨ Get feedback and investor recommendations for your deal memos.
✌️ Learn and grow together as a community!
H7 BioCapital focuses on investing in life sciences, therapeutics, medtech, and pharmaceutical innovation. The fellowship aims to develop the next generation of biotech investors by providing them with the necessary skills and network to succeed in the industry.
Candidates must hold a Ph.D. or M.D. degree and have prior pharmaceutical or biotech industry experience. Preference is given to those with venture capital, consulting, or business development experience.
This is an unpaid fellowship.
There is no cost to participate in the fellowship.
The fellowship lasts for 6 months, with a flexible part-time commitment of approximately 10 hours per week.
The fellowship requires a part-time commitment of approximately 10 hours per week.
The program is primarily remote, allowing flexibility for participants.
Program announcement on H7 BioCapital website and venture capital fellowship databases.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.